ArticleOncotarget2026

Retraction: LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1n.

Zhu Kun-Peng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.